These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 19173785)

  • 21. Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma.
    Wahn U; Bachert C; Heinrich J; Richter H; Zielen S
    Allergy; 2019 Mar; 74(3):594-604. PubMed ID: 30183091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sublingual immunotherapy for allergic rhinoconjunctivitis--the seeming and the real.
    Reider N
    Int Arch Allergy Immunol; 2005 Jul; 137(3):181-6. PubMed ID: 15947473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allergen immunotherapy in asthma.
    Nakagome K; Nagata M
    Allergol Int; 2024 Oct; 73(4):487-493. PubMed ID: 38955611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between allergen immunotherapy and omalizumab for treating asthma.
    Braido F; Corsico A; Rogkakou A; Ronzoni V; Baiardini I; Canonica GW
    Expert Rev Respir Med; 2015 Apr; 9(2):129-34. PubMed ID: 25578528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical considerations in the use of sublingual immunotherapy for allergic rhinitis.
    Lee S; Nolte H; Benninger MS
    Am J Rhinol Allergy; 2015; 29(2):106-14. PubMed ID: 25785750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcutaneous Immunotherapy and Sublingual Immunotherapy: Comparative Efficacy, Current and Potential Indications, and Warnings--United States Versus Europe.
    Nelson HS; Makatsori M; Calderon MA
    Immunol Allergy Clin North Am; 2016 Feb; 36(1):13-24. PubMed ID: 26617224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allergen immunotherapy and asthma.
    Tosca MA; Olcese R; Licari A; Ciprandi G
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():46-48. PubMed ID: 32017211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O; Hörmann K; Klimek L
    MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subcutaneous immunotherapy.
    Roche AM; Wise SK
    Int Forum Allergy Rhinol; 2014 Sep; 4 Suppl 2():S51-4. PubMed ID: 25182356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical efficacy of immunotherapy in allergic rhinitis.
    Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C
    Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 27658025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A milestone in house dust-mite-allergen immunotherapy: the new sublingual tablet S-524101 (actair).
    Bahceciler NN; Babayigit Hocaoglu A; Galip N
    Expert Rev Vaccines; 2014 Dec; 13(12):1427-38. PubMed ID: 25345538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allergen immunotherapy in asthma: current evidence and future requirements.
    Madonini E; Musarra A
    Eur Ann Allergy Clin Immunol; 2011 Aug; 43(4):103-10. PubMed ID: 21980797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and experimental treatment of allergic asthma with an emphasis on allergen immunotherapy and its mechanisms.
    Fiala S; Fleit HB
    Clin Exp Immunol; 2023 Apr; 212(1):14-28. PubMed ID: 36879430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of sublingual immunotherapy in children.
    Arasi S; Passalacqua G; Caminiti L; Crisafulli G; Fiamingo C; Pajno GB
    Expert Rev Clin Immunol; 2016; 12(1):49-56. PubMed ID: 26496537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy, safety, and practical considerations.
    Cox L
    Curr Allergy Asthma Rep; 2007 Nov; 7(6):410-20. PubMed ID: 17986370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective?
    Nelson HS
    J Allergy Clin Immunol Pract; 2014; 2(2):144-9; quiz 150-1. PubMed ID: 24607040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Efficacy of Allergen-Specific Immunotherapy from Patient and Physician Perspectives.
    Shin YS; Jung JW; Park JW; Choi JH; Kwon JW; Lee S; Kim JH; Lee SM; Ahn YM; Han MY;
    Yonsei Med J; 2019 May; 60(5):446-453. PubMed ID: 31016906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of allergen-specific immunotherapy in children.
    De Filippo M; Votto M; Caminiti L; Panasiti I; Carella F; De Castro G; Landi M; Olcese R; Vernich M; Marseglia GL; Ciprandi G; Barberi S
    Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):27-30. PubMed ID: 35080302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical contraindications to allergen immunotherapy: an EAACI position paper.
    Pitsios C; Demoly P; Bilò MB; Gerth van Wijk R; Pfaar O; Sturm GJ; Rodriguez del Rio P; Tsoumani M; Gawlik R; Paraskevopoulos G; Ruëff F; Valovirta E; Papadopoulos NG; Calderón MA
    Allergy; 2015 Aug; 70(8):897-909. PubMed ID: 25913519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Allergic march in children, from rhinitis to asthma: management, indication of immunotherapy].
    Scheinmann P; Pham Thi N; Karila C; de Blic J
    Arch Pediatr; 2012 Mar; 19(3):330-4. PubMed ID: 22306361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.